WEIGHT LOSS

Per page:
Sort products:
ACXION AP PHENTERMINE 30MG 30TABS XT
ACXION AP PHENTERMINE 30MG 30TABS XT
  • BRAND NAME: ACXION AP
  • ACTIVE INGREDIENT: PHENTERMINE 30MG
  • LABORATORY: IFA CELTICS
In stock
$109.10 USD
ACXION C PHENTERMINE 30MG 30CAPSULES
ACXION C PHENTERMINE 30MG 30CAPSULES
  • BRAND NAME: ACXION C
  • ACTIVE INGREDIENT: PHENTERMINE 30MG
  • LABORATORY: IFA CELTICS
In stock
$108.71 USD
ACXION PHENTERMINE 15MG TABS 30
ACXION PHENTERMINE 15MG TABS 30
  • BRAND NAME: ACXION
  • ACTIVE INGREDIENT: PHENTERMINE 15MG
  • LABORATORY: IFA CELTICS
In stock
$64.79 USD
ACXION PHENTERMINE 30MG 30TABS
ACXION PHENTERMINE 30MG 30TABS
  • BRAND NAME: ACXION
  • ACTIVE INGREDIENT: PHENTERMINE 30MG
  • LABORATORY: IFA CELTICS
In stock
$99.80 USD
ACXION PHENTERMINE 6.4MG 30TABS
ACXION PHENTERMINE 6.4MG 30TABS
  • BRAND NAME: ACXION
  • ACTIVE INGREDIENT: PHENTERMINE 6.4MG
  • LABORATORY: IFA CELTICS
In stock
$37.80 USD
ANDANZA ORLISTAT 120MG 30TABS
ANDANZA ORLISTAT 120MG 30TABS
  • BRAND NAME: ANDANZA
  • ACTIVE INGREDIENT: ORLISTAT 120MG
  • LABORATORY: MEDIX
In stock
$79.88 USD
ASENLIX CLOBENZOREX 30MG 60CAPS
ASENLIX CLOBENZOREX 30MG 60CAPS
  • BRAND NAME: ASENLIX
  • ACTIVE INGREDIENT: CLOBENZOREX 30MG
  • LABORATORY: SANOFI-AVENTIS
In stock
$345.10 USD
DISEPSIN TERFAMEX PHENTERMINE 30MG 30CAPS
DISEPSIN TERFAMEX PHENTERMINE 30MG 30CAPS
  • BRAND NAME: DISEPSIN TERFAMEX
  • ACTIVE INGREDIENT: PHENTERMINE 30MG
  • LABORATORY: MEDIX
In stock
$103.28 USD
ITRAVIL AP CLOBENZOREX 60MG 30CAPS XR
ITRAVIL AP CLOBENZOREX 60MG 30CAPS XR
  • BRAND NAME: ITRAVIL AP
  • ACTIVE INGREDIENT: CLOBENZOREX 60MG
  • LABORATORY: IFA CELTICS
In stock
$183.88 USD
ITRAVIL AP CLOBENZOREX 60MG 60TABS XR
ITRAVIL AP CLOBENZOREX 60MG 60TABS XR
  • BRAND NAME: ITRAVIL AP
  • ACTIVE INGREDIENT: CLOBENZOREX 60MG
  • LABORATORY: IFA CELTICS
In stock
$250.00 USD
ITRAVIL CLOBENZOREX 30MG 60CAPS
ITRAVIL CLOBENZOREX 30MG 60CAPS
  • BRAND NAME: ITRAVIL
  • ACTIVE INGREDIENT: CLOBENZOREX 30MG
  • LABORATORY: IFA CELTICS
In stock
$179.76 USD
LOSE MAZINDOL 1MG 30TABS
LOSE MAZINDOL 1MG 30TABS
  • BRAND NAME: LOSE
  • ACTIVE INGREDIENT: MAZINDOL 1MG
  • LABORATORY: IFA CELTICS
In stock
$77.40 USD
LOSE MAZINDOL 2MG 30TABS
LOSE MAZINDOL 2MG 30TABS
  • BRAND NAME: LOSE
  • ACTIVE INGREDIENT: MAZINDOL 2MG
  • LABORATORY: IFA CELTICS
In stock
$95.20 USD
NOREX AMFEPRAMONE 50MG 30TABS
NOREX AMFEPRAMONE 50MG 30TABS
  • BRAND NAME: NOREX
  • ACTIVE INGREDIENT: AMPHEPRAMONE 50MG
  • LABORATORY: IFA CELTICS
In stock
$89.00 USD
NOREX AP AMFEPRAMONE 50MG 30TABS XR
NOREX AP AMFEPRAMONE 50MG 30TABS XR
  • BRAND NAME: NOREX AP
  • ACTIVE INGREDIENT: AMPHEPRAMONE 75MG
  • LABORATORY: IFA CELTICS
In stock
$117.68 USD
OBECLOX CLOBENZOREX 30MG 60CAPS
OBECLOX CLOBENZOREX 30MG 60CAPS
  • BRAND NAME: OBECLOX
  • ACTIVE INGREDIENT: CLOBENZOREX 30MG
  • LABORATORY: MEDIX
In stock
$385.90 USD
ORLISTAT 120MG 60CAPS
ORLISTAT 120MG 60CAPS
  • ACTIVE INGREDIENT: ORLISTAT 120MG
  • LABORATORY: RAAM
In stock
$55.96 USD
RYBELSUS SEMAGLUTIDE 14MG 30TABS
RYBELSUS SEMAGLUTIDE 14MG 30TABS
  • ACTIVE INGREDIENT: SEMAGLUTIDE 14MG
  • LABORATORY: NOVO NORDISK
In stock
$610.00 USD
RYBELSUS SEMAGLUTIDE 3MG 30TABS
RYBELSUS SEMAGLUTIDE 3MG 30TABS
  • ACTIVE INGREDIENT: SEMAGLUTIDE 3MG
  • LABORATORY: NOVO NORDISK
In stock
$350.00 USD
RYBELSUS SEMAGLUTIDE 7MG 30TABS
RYBELSUS SEMAGLUTIDE 7MG 30TABS
  • ACTIVE INGREDIENT: SEMIGLUTIDE 7MG
  • LABORATORY: NOVO NORDISK
In stock
$534.00 USD
WEIGHT LOSS

Obesity is a medical condition in which excess body fat has accumulated to an extent that it may have a negative effect on health. People are generally considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height—despite known allometric inaccuracies[a]—is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower values. Obesity is correlated with various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, and osteoarthritis. High BMI is a marker of risk, but not proven to be a direct cause, for diseases caused by diet, physical activity, and environmental factors. A reciprocal link has been found between obesity and depression, with obesity increasing the risk of clinical depression and also depression leading to a higher chance of developing obesity.

 

Obesity has individual, socioeconomic, and environmental causes, including diet, physical activity, automation, urbanization, genetic susceptibility, medications, mental disorders, economic policies, endocrine disorders, and exposure to endocrine-disrupting chemicals. While a majority of obese individuals at any given time are attempting to lose weight and often successful, research shows that maintaining that weight loss over the long term proves to be rare. The reasons for weight cycling are not fully understood but may include decreased energy expenditure combined with increased biological urge to eat during and after caloric restriction. More studies are needed to determine if weight cycling and yo-yo dieting contribute to inflammation and disease risk in obese individuals.

 

Obesity prevention requires a complex approach, including interventions at community, family, and individual levels. Changes to diet and exercising are the main treatments recommended by health professionals. Diet quality can be improved by reducing the consumption of energy-dense foods, such as those high in fat or sugars, and by increasing the intake of dietary fiber. However, large-scale analyses have found an inverse relationship between energy density and energy cost of foods in developed nations. Low-income populations are more likely to live in neighborhoods that are considered "food deserts" or "food swamps" where nutritional groceries are less available. Medications can be used, along with a suitable diet, to reduce appetite or decrease fat absorption. If diet, exercise, and medication are not effective, a gastric balloon or surgery may be performed to reduce stomach volume or length of the intestines, leading to feeling full earlier or a reduced ability to absorb nutrients from food.